Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th – 11th in San Francisco
BOCA RATON, Fla., Jan. 3, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, CEO and Arthur Levine, CFO will participate in the Annual JP Morgan Healthcare […]
Sensus Healthcare Receives the BioFlorida Company of the Year Award
BOCA RATON, Fla., Dec. 13, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today that it has been named the winner of the BioFlorida Company of the Year Award at […]
Sensus Healthcare to Participate in Two Upcoming Investor Conferences on November 30th and December 1st
— Evercore ISI MedTools Investor Conference in Boston, MA — Drexel Hamilton’s Emerging Growth Conference in New York, NY BOCA RATON, Fla., Nov. 16, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), […]
Sensus Healthcare Reports Third Quarter 2016 Results
– Q3 revenues increased 58% year-over-year to $3.33 million – Worldwide installed base increased to 256 units BOCA RATON, Fla., Nov. 3, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today reported […]
Sensus Healthcare to Announce Third Quarter 2016 Results on November 3, 2016
BOCA RATON, Fla., Oct. 20, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its third quarter 2016 financial results on Thursday, November 3, 2016 after the market […]
Sensus Healthcare to Participate in Important Dermatological and Institutional Investor Conferences from October 20th to October 23rd
–2016 Fall Clinical Dermatology Conference in Las Vegas, NV –Dawson James 2016 Small Cap Growth Stock Conference in Jupiter, FL BOCA RATON, Fla., Oct. 6, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy […]
Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
– Sensus Credited with Advancing Superficial Radio Therapy as Viable Treatment Option for NMSC – BOCA RATON, Fla., Sept. 7, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today it […]
Sensus Healthcare to Sponsor First International Keloid Symposium on September 8 and 9 in New York
BOCA RATON, Fla., Aug. 31, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that the Company will sponsor the First International Keloid Symposium to be held at The Rockefeller University […]
Sensus Healthcare Reports Second Quarter 2016 Results
– Q2 revenues increased 49% year-over-year to $3.6 million – Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA RATON, Fla., Aug. 4, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of […]
